VCEL - Vericel Corp
IEX Last Trade
51.63
0.080 0.155%
Share volume: 277,841
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$51.55
0.08
0.16%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-09 | 2023-02-23 | 2023-05-10 | 2023-08-02 | 2023-11-08 | 2024-02-29 | 2024-05-08 | 2024-08-01 | |
| Assets | |||||||||
| Total Assets | 248.017 M | 273.003 M | 265.096 M | 310.711 M | 318.125 M | 353.657 M | 356.661 M | 376.839 M | |
| Current Assets | 166.375 M | 186.866 M | 177.545 M | 182.871 M | 186.211 M | 205.631 M | 189.718 M | 197.386 M | |
| Inventories | 16.729 M | 15.986 M | 15.370 M | 13.883 M | 12.621 M | 13.087 M | 13.557 M | 14.887 M | |
| Other Current Assets | 4.410 M | 4.803 M | 4.540 M | 5.044 M | 5.430 M | 6.853 M | 7.775 M | 6.432 M | |
| Short Term Investments | 4.410 M | 4.803 M | 4.540 M | 5.044 M | 5.430 M | 6.853 M | 7.775 M | 6.432 M | |
| Total Receivables | 34.296 M | 46.539 M | 38.359 M | 38.319 M | 39.729 M | 58.356 M | 49.934 M | 47.996 M | |
| Current Cash | 110.940 M | 119.538 M | 119.276 M | 97.831 M | 105.343 M | 109.557 M | 110.648 M | 102.508 M | |
| Total Non-current Assets | 81.642 M | 86.137 M | 87.551 M | 127.840 M | 131.914 M | 148.026 M | 166.943 M | 179.453 M | |
| Property Plant Equipment | 15.918 M | 15.837 M | 18.197 M | 23.408 M | 30.216 M | 41.635 M | 56.392 M | 73.086 M | |
| Other Assets | 1.357 M | 8.803 M | 8.593 M | 1.196 M | 1.142 M | 771.000 K | 717.000 K | 664.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 7.188 M | 7.031 M | 6.875 M | 6.719 M | 6.563 M | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 248.017 M | 273.003 M | 265.096 M | 310.711 M | 318.125 M | 353.657 M | 356.661 M | 376.839 M | |
| Total liabilities | 70.180 M | 80.731 M | 71.118 M | 111.783 M | 113.745 M | 127.705 M | 122.765 M | 133.862 M | |
| Total current liabilities | 27.004 M | 37.463 M | 28.753 M | 35.611 M | 35.946 M | 45.749 M | 36.470 M | 43.863 M | |
| Accounts Payable | 8.113 M | 16.930 M | 11.125 M | 14.401 M | 15.051 M | 22.347 M | 19.432 M | 25.216 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 28.000 K | 65.000 K | 100.000 K | 154.000 K | 198.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 28.000 K | 65.000 K | 100.000 K | 154.000 K | 198.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 177.837 M | 192.272 M | 193.978 M | 198.928 M | 204.380 M | 225.952 M | 233.896 M | 242.977 M | |
| Common stock | 47.182 M | 47.236 M | 47.387 M | 47.572 M | 47.649 M | 47.752 M | 48.141 M | 48.686 M | |
| Retained earnings | -405.917 M | -399.995 M | -407.490 M | -412.510 M | -416.170 M | -403.177 M | -407.039 M | -411.721 M |